318
Participants
Start Date
May 6, 2019
Primary Completion Date
December 27, 2022
Study Completion Date
December 27, 2022
anamorelin HCl
100 mg anamorelin HCl (administered as 100 mg tablets in the fasted condition)
Placebo Oral Tablet
Placebo (administered as matching placebo tablets in the fasted condition)
Jules Bordet Institut, Brussels
Saint Luc University Hospital, Brussels
University Hospital Antwerp (UZA), Edegem
"Medical Center VERUM Limited Liability Company", Kyiv
The Royal Melbourne Hospital, Parkville
St Vincent's Hospital Melbourne, Fitzroy
Barwon Health, The McKellar Centre, North Geelong
Gold Coast University Hospital, Southport
Flinders Medical Centre, Bedford Park
Calvary Central Districts Hospital, Elizabeth Vale
Charleroi Grand Hospital (GHDC), Charleroi
General Hospital Delta, Roeselare
University Hospital Center Zagreb, Zagreb
Hematology Oncology Center at Nyack Hospital, Nyack
University of Rochester, Medical Center, Rochester
University Hospital Center Split, Split
Duke Cancer Center, Durham
Bond & Steele Clinic P.A., Winter Haven
"Public Entreprise Poltava Regional Clinical Oncology Center under Poltava Regional Council", Poltava
Toledo Clinic Cancer Center-Toledo, Toledo
Public Non-Profit Enterprise 'Ternopil Regional Clinical Oncology Center'' under Temopil Regional Council, Ternopil
"Medical Center MEDICAL PLAZA of the Limited Liability Company EKODNIPRO", Dnipro
Cancer and Hematology Centers of Western Michigan, Grand Rapids
Siouxland Regional Cancer Center dba June E.Nylen Cancer Center, Sioux City
Presence Infusion Care, Skokie
"Communal Non-Profit Enterprise Regional Center of Oncology", Kharkiv
Publ Non- Profit Ent. under Kharkiv Reg. Council, Kharkiv
Cancer Center of Kansas, Wichita
"Medical Center of Limited Liability Company ONCOLIFE", Zaporizhzhya
The University of Arizona Cancer Center - North Campus, Tucson
Compassionate Care Research Group, Inc., at Compassionate Cancer Care Medical Group, Inc., Fountain Valley
Pacific Cancer Medical Center, Inc, Anaheim
CBCC Global Research Inc, Bakersfield
Marin Cancer Care, Greenbrae
Oncology Center of Moskovskiy District, Saint Petersburg
AV Medical Group, Saint Petersburg
Palliative Care Center Devita, Saint Petersburg
City Clinical Oncology Center, Saint Petersburg
"Sf. Nectarie Oncology Center, Medical Oncology Department", Craiova
S.C. Oncomed SRL, Medical Oncology Department, Timișoara
Oncology Center #2, Sochi
Pyatigorsk Interdistric Oncology Center, Pyatigorsk
"Prof. Dr. Ion Chiricuta Institute of Oncology, Medical Oncology Department", Cluj-Napoca
Volgograd Regional Clinical Oncology Center, Volgograd
Republican Clinical Oncology Center, Kazan'
Ogaryov Mordovia National Research State University, Republican Oncology Center, Saransk
SC Oncopremium Team SRL, Medical Oncology Department, Baia Mare
Samara Regional Clinical Oncology Center, Samara
Topmed Medical Center, Medical Oncology Department, Târgu Mureş
Sf. Ioan cel Nou Country Emergency Hospital, Oncology Department, Suceava
Smilow Cancer Hospital at Yale-New Haven, Waterbury
Dartmouth-Hitchcock Medical Center, Lebanon
New Jersey Hematology Oncology Associates Inc, Brick
Hunterdon Hematology Oncology LLC, Flemington
The University of Texas MD Anderson Cancer Center, Houston
General Hospital Pula, Pula
Wladyslaw Bieganski Regional Specialist Hospital, Clinical Oncology Department, Grudziądz
"VEGAMED Non-Public Healthcare Facility", Katowice
MSF Institute Ltd. Santa Familia Medical Institute, Lodz
MED - POLONIA Ltd., Poznan
Specialist Hospital in Prabuty sp. z o.o. [limited liability company], Department of Pulmonology, Prabuty
Maria Skfodowska-Curie Institute of Oncology, Department of Lung and Thoracic Cancers, Warsaw
Mazovian Oncology Hospital, Oncology Outpatient Clinic, Wieliszew
Alexandru Trestioreanu Institute of Oncology, Bucharest
"Private Enterprise First Private Clinic", Kyiv
Lead Sponsor
Helsinn Healthcare SA
INDUSTRY